4.3. Atherosclerosis Risk Variant A of rs2107595 from Chr7p21.1 Interferes with E2F3 in Putative Enhancer Region, Which Leads to HDAC9 Activation. This evidence concerns the gene HDAC9 and atherosclerosis.